Mayne Pharma Group Limited
Symbole: MYX.AX
ASX
6.8
AUDPrix du marché aujourd'hui
-2.3865
Ratio P/E
-0.0091
Ratio PEG
578.51M
Cap MRK
- 0.00%
Rendement DIV
Mayne Pharma Group Limited (MYX-AX) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 229.2 | 97.1 | 98.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 127.5 | 1.3 | 0 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 209.5 | 283 | 193.3 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 82.7 | 108.9 | 102.5 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 32.2 | 22.6 | 22.3 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 553.6 | 511.6 | 416.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 51.5 | 225.9 | 221.6 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 22.1 | 20.3 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 617.3 | 427.5 | 636.2 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 617.3 | 449.6 | 656.5 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -22.1 | -20.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 23.4 | 133.7 | 187.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 2.3 | 4.5 | 16.7 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 694.5 | 791.5 | 1061.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 1248.1 | 1303.1 | 1478.1 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 32 | 63.6 | 42.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 14.4 | 408 | 54 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 1.2 | 0 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 28.5 | 5.7 | 285.8 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 4.6 | 0 | 7 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 256.9 | 156.9 | 125.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 302.8 | 135.6 | 484 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.6 | 5.7 | 7 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 613.8 | 764.9 | 706.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 1233.7 | 1238.5 | 1238.5 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -769.8 | -840.3 | -559.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 170.4 | 147.7 | 88.9 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 634.4 | 545.9 | 768.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1248.1 | 1303.1 | 1478.1 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -7.7 | 3.2 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 634.4 | 538.2 | 771.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 127.5 | 1.3 | -20.3 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 47.5 | 413.7 | 346.8 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | -54.2 | 316.6 | 248.5 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -317.4 | -209.5 | -208.4 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 65.4 | 55.2 | 68.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 50 | 63.4 | -43.9 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 6.8 | 4.6 | 7.7 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 145.4 | -8.9 | -13.6 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 118.7 | -66.1 | -3.2 | |||||||||||||||||
cash-flows.row.inventory | 0 | -12.1 | -2.4 | -25.9 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 45.3 | 60.7 | 16.4 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | -6.5 | -1.1 | -0.9 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 6.6 | 78.6 | 237.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -219.6 | -11.9 | -25.1 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 842.2 | 5.2 | 0 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -127.5 | 0 | 0 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -21.6 | -21.8 | -24.1 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 473.5 | -28.5 | -49.2 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -376 | -39.8 | -25.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.3 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -6.2 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -45.3 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -6.2 | 76.8 | -3 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -431.5 | 37 | -28.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2.9 | 6.8 | -9 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4.6 | -1.3 | -39.8 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 101.7 | 97.1 | 98.4 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 97.1 | 98.4 | 138.2 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -43.1 | -16.6 | 47.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -219.6 | -11.9 | -25.1 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -262.7 | -28.5 | 22.2 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 183.6 | 157.1 | 400.8 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 156.7 | 133.4 | 273.8 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 26.8 | 23.7 | 127 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 12.6 | 74.4 | 6.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 213.3 | 145.6 | 125.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 370 | 279 | 399.4 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 6.7 | 0.5 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 10.5 | 11.5 | 13.3 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -83.3 | -23.7 | -265.3 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12.6 | 74.4 | 6.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -83.3 | -23.7 | -265.3 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 10.5 | 11.5 | 13.3 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 65.4 | 55.2 | 68.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | -186.4 | -121.9 | 1.4 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -269.7 | -145.6 | -263.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 47.7 | 74.5 | -54.8 | |||||||||||||||||
income-statement-row.row.net-income | 0 | -316.4 | -281.3 | -208.4 |
Questions fréquemment posées
Quel est le total de Mayne Pharma Group Limited (MYX.AX) de l'actif total?
Mayne Pharma Group Limited (MYX.AX) Le total des actifs est 1248134000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.437.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -0.359.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.897.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.381.
Qu'est-ce que Mayne Pharma Group Limited (MYX.AX) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -316419000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 47505000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 213282000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.